Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DILTIAZ SR - 90MG/SRC | 90MG | CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2017-08-13 | 2017-10-05 | 19030 |
APO-DILTIAZ SR - SRC 120MG | 120MG | CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2017-08-13 | 2017-10-05 | 19033 |
APO-DILTIAZ SR - SRC 60MG | 60MG | CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2017-08-13 | 2017-10-05 | 19027 |
APO-DIPIVEFRIN | 0.1% | LIQUID | Actual shortage | 2017-08-16 | 2017-10-05 | 19598 |
APO-DIPYRIDAMOLE-FC TAB 75MG | Resolved | 2018-08-21 | 2018-09-17 | 58589 | ||
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-04-16 | 2018-05-14 | 46024 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-06-06 | 2017-07-17 | 12059 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2017-06-15 | 2017-07-26 | 12805 |
APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-01-06 | 2023-01-20 | 180081 |
APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-03-16 | 2023-03-23 | 187226 |
APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-05-06 | 190846 |
APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-05-06 | 2023-05-12 | 191889 |
APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-06-16 | 2023-07-07 | 195097 |
APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-06-23 | 2023-07-07 | 196292 |
APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-07-13 | 2023-09-22 | 198500 |
APO-DIVALPROEX | 125MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-07-21 | 2023-09-01 | 199530 |
APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-07-21 | 2023-10-27 | 199533 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-01-03 | 2018-02-12 | 34844 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-01-03 | 2018-03-06 | 34847 |
APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2024-07-04 | 2024-08-16 | 232286 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |